Secondary hypertension
246 results
1 - 100
Secondary hypertension 
Indomethacin for intracranial hypertension secondary to severe traumatic brain injury in adults
Useful history, physical, and laboratory findings for predicting secondary hypertension in children and adolescents- Fewer than 4% of children with newly diagnosed hypertension in primary care or school settings have secondary causes
- Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases
- Hypertension: investigations, treatment initiation and non-pharmacological treatment
- Hypertension in children
- Intracerebral haemorrhage
- Phosphodiesterase 5 inhibitors for pulmonary hypertension
- Cushing's syndrome
- Drug treatment for hypertension
- Intracranial aneurysm and subarachnoid haemorrhage (SAH)
- Prostacyclin for pulmonary hypertension in adults
- Phosphodiesterase 5 inhibitors for pulmonary hypertension: Cochrane systematic review
- Elevated blood pressure in pregnancy (gestational hypertension, pre-eclampsia)
- Roselle for hypertension in adults
- Antihypertensive therapy beneficial for patients with BP < 140/90 and history of CVD
- Hypertension treatment effective even after age 80
- Spironolactone for hypertension
- Angiotensin receptor blockers or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation
- Treatment of mild chronic hypertension during pregnancy is beneficial
- Hydralazine for essential hypertension
- New US guidelines suggest risk-based approach to stage 1 hypertension
- Bariatric surgery in obese patients with hypertension can produce normotension in some of them (GATEWAY)
- Venous insufficiency of the lower limbs
- Beta‐blockers for preventing stroke recurrence
- First‐line drugs for hypertension
- Phosphodiesterase 5 inhibitors for pulmonary hypertension
- Antiplatelet agents and anticoagulants for hypertension
- Weak evidence that optimal neonatal outcomes are associated with delivery at 39 weeks for pregnant individuals with mild chronic hypertension
- Raynaud's phenomenon (RP) or white finger disease
- Methyldopa for primary hypertension: Cochrane systematic review
- Hypokalaemia
- Renin inhibitors versus angiotensin receptor blockers for primary hypertension
- Inhaled iloprost for pulmonary hypertension
- Cesarean rates and neonatal outcomes similar with induction vs expectant management with unripe cervix
- Headache
- Guided imagery for treating hypertension in pregnancy
- Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertension
- Riociguat for pulmonary hypertension
- ASA for hypertension
- IgA nephropathy
- Pharmacotherapy for mild hypertension
- Eplerenone for hypertension
- Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus: Cochrane systematic review
- Long‐term effects of weight‐reducing diets in people with hypertension
- Cerebral infarction (ischaemic stroke)
- Pharmacotherapy for mild hypertension
- Guanylate cyclase stimulators for pulmonary hypertension
- Interventions for altering blood pressure in people with acute subarachnoid haemorrhage
- Glomerulonephrites
- Pharmacotherapy for hypertension in adults 60 years or older
- Treatment of hypertension in peripheral arterial disease
- Different types of dietary advice for women with gestational diabetes mellitus
- Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
- Higher BP target does not reduce mortality in septic patients (SEPSISPAM)
- Proteinuria
- ACE = ARB for secondary CV prevention; combination worse (ONTARGET)
- Blood pressure targets in adults with hypertension
- Long‐term effects of weight‐reducing drugs in people with hypertension
- Prostacyclin for pulmonary hypertension
- First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension: Cochrane systematic review
- No difference in major vascular complications with different blood pressure strategies after noncardiac surgery (POISE-3)
- Calcium channel blockers versus other classes of drugs for hypertension